Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
W B Graninger, … , P Goldman, S J Korsmeyer
W B Graninger, … , P Goldman, S J Korsmeyer
Published November 1, 1987
Citation Information: J Clin Invest. 1987;80(5):1512-1515. https://doi.org/10.1172/JCI113235.
View: Text | PDF
Research Article Article has an altmetric score of 3

Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

  • Text
  • PDF
Abstract

We examined the expression of the Bcl-2 gene at chromosome segment 18q21, that is translocated into the Ig heavy chain gene locus in t(14;18) bearing lymphomas. Bcl-2, while B cell associated, is expressed in a variety of hematopoietic lineages including T cells. Bcl-2 mRNA levels are high during pre-B cell development, the time at which the t(14;18) translocation occurs, but are down regulated with maturation. Like certain other oncogenes, Bcl-2 is quiescent in resting B cells but up-regulated with B cell activation. Mature B cell lymphomas with a t(14;18) have log-folds more mRNA than matched counterparts without the translocation. A sensitive S1 protection assay revealed that all transcripts in t(14;18) B cells were Bcl-2-Ig fusion mRNAs and originated from the translocated allele. Thus, there is a marked deregulation of Bcl-2 when it is introduced into the Ig locus in t(14;18) lymphomas.

Authors

W B Graninger, M Seto, B Boutain, P Goldman, S J Korsmeyer

×

Total citations by year

Year: 2021 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1986 1971 Total
Citations: 1 3 2 2 2 2 5 2 6 7 3 4 5 5 9 4 6 11 8 6 6 6 9 11 11 22 19 6 14 9 5 6 1 1 219
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (219)

Title and authors Publication Year
Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci
S Sungalee, Y Liu, RA Lambuta, N Katanayeva, MD Collier, D Tavernari, S Roulland, G Ciriello, E Oricchio
Nature Genetics 2021
Cancer Metabolism and the Evasion of Apoptotic Cell Death
A Sharma, LH Boise, M Shanmugam
Cancers 2019
Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)
Z Zhu, T Li, X Zhang, Z Zhang, D Zhu, P Lin, S Tu, W Ren
International journal of oncology 2019
Ovarian cancer stem cells and targeted therapy
V Keyvani, M Farshchian, SA Esmaeili, H Yari, M Moghbeli, SR Nezhad, MR Abbaszadegan
Journal of Ovarian Research 2019
BCL-2 as therapeutic target for hematological malignancies
GF Perini, GN Ribeiro, JV Neto, LT Campos, N Hamerschlak
Journal of Hematology & Oncology 2018
Do Fungi Undergo Apoptosis-Like Programmed Cell Death?
JM Hardwick, DA Hogan, J Berman
mBio 2018
BCL-2: Long and winding path from discovery to therapeutic target
RL Schenk, A Strasser, G Dewson
Biochemical and Biophysical Research Communications 2017
The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma
X Hu, E Baytak, J Li, B Akman, K Okay, G Hu, A Scuto, W Zhang, C Küçük
Leukemia Research 2017
Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
PM Reagan, JW Friedberg
Current Treatment Options in Oncology 2015
Chromosomal Translocations and Genome Rearrangements in Cancer
JD Rowley, MM Beau, TH Rabbitts
2015
Follicular lymphoma: too many reminders for a memory B cell
Srividya Swaminathan, Markus Muschen
Journal of Clinical Investigation 2014
Targeting BCL2-Proteins for the Treatment of Solid Tumours
M Vogler
Advances in Medicine 2014
Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN
L Shen, L Suresh, K Malyavantham, P Kowal, J Xuan, MJ Lindemann, JL Ambrus
Journal of immunology (Baltimore, Md. : 1950) 2013
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype
K Kunkalla, Y Liu, C Qu, V Leventaki, NK Agarwal, RR Singh, F Vega
Annals of Hematology 2013
Mechanisms of chemoresistance in cancer stem cells
LN Abdullah, EK Chow
Clinical and Translational Medicine 2013
Circulating t(14;18)-Positive Cells in Healthy Individuals – Association with Age and Sex but not with Smoking
C Hirt, K Weitmann, F Schüler, T Kiefer, CS Rabkin, W Hoffmann, G Dölken
Leukemia & Lymphoma 2013
Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo
J Lin, Y Wu, D Yang, Y Zhao
Oncology reports 2013
Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence
MA Fischer, I Moreno-Miralles, A Hunt, BJ Chyla, SW Hiebert
The EMBO Journal 2012
Chromosomal translocations among the healthy human population: implications in oncogenesis
M Nambiar, SC Raghavan
Cellular and Molecular Life Sciences 2012
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff
Herbal Medicine 2011
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas
AL Iscache, S Menoret, L Tesson, S Remy, C Usal, C Pedros, A Saoudi, R Buelow, I Anegon
International Immunology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
The Immunoglobulin Heavy Chain Gene 3’ Enhancers Induce Bcl2 Deregulation and Lymphomagenesis in Murine B Cells
H Xiang, EJ Noonan, J Wang, H Duan, L Ma, S Michie, LM Boxer
Leukemia 2011
A Case of an Abdominal Mass: Follicular Lymphoma
TL Walker, GE Lopez
The Permanente journal 2011
Genomic profiles in B cell lymphoma
M Seto
International Journal of Hematology 2010
Double-hit B-cell lymphomas
SM Aukema, R Siebert, E Schuuring, GW van Imhoff, HC Kluin-Nelemans, EJ Boerma, PM Kluin
Blood 2010
Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation
RR Singh, JE Kim, Y Davuluri, E Drakos, JH Cho-Vega, HM Amin, F Vega
Leukemia 2010
Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line
N Masir, LJ Campbell, M Jones, DY Mason
Pathology 2010
ζ-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia
A Lapucci, M Lulli, A Amedei, L Papucci, E Witort, FD Gesualdo, F Bertolini, G Brewer, A Nicolin, A Bevilacqua, N Schiavone, D Morello, M Donnini, S Capaccioli
The FASEB Journal 2010
BCL-2 Protein Family
C Hetz
2010
The BCL-2 5′ Untranslated Region Contains an RNA G-Quadruplex-Forming Motif That Modulates Protein Expression
R Shahid, A Bugaut, S Balasubramanian
Biochemistry 2010
BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations
N Masir, LJ Campbell, LK Goff, M Jones, T Marafioti, J Cordell, AJ Clear, TA Lister, DY Mason, AM Lee
British Journal of Haematology 2009
Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma
L Goff, K Summers, S Iqbal, J Kuhlmann, M Kunz, T Louton, A Hagenbeek, F Morschhauser, B Putz, A Lister, A Rohatiner
Journal of Clinical Oncology 2009
BLyS Ligands and Receptors
MP Cancro
2009
The anaplastic lymphoma kinase in the pathogenesis of cancer
R Chiarle, C Voena, C Ambrogio, R Piva, G Inghirami
Nature Reviews Cancer 2008
Functional long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells
H Duan, H Xiang, L Ma, LM Boxer
Oncogene 2008
Therapeutic Modulation of Apoptosis: Targeting the BCL-2 Family at the Interface of the Mitochondrial Membrane
KN Nemec, AR Khaled
Yonsei Medical Journal 2008
Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
KJ Cheung, SP Shah, C Steidl, N Johnson, T Relander, A Telenius, B Lai, KP Murphy, W Lam, AJ Al-Tourah, JM Connors, RT Ng, RD Gascoyne, DE Horsman
Blood 2008
Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: Insight into B-cell lymphomagenesis
E Kondo, T Yoshino
Pathology International 2007
Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals
C Hirt, G Dölken, S Janz, CS Rabkin
British Journal of Haematology 2007
The cancer treatment revolution
DG Nathan
Transactions of the American Clinical and Climatological Association 2007
Roles of Smad3 in TGF-beta signaling during carcinogenesis
C Millet, YE Zhang
Critical reviews in eukaryotic gene expression 2007
Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas
SB Karauzum, D Yasar, E Dirice, N Imir, G Luleci, ON Ozes
Growth Factors 2007
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
YA Yang, GM Zhang, L Feigenbaum, YE Zhang
Cancer Cell 2006
Association of Clinical Status of Follicular Lymphoma Patients after Autologous Stem Cell Transplant and Quantitative Assessment of Lymphoma in Blood and Bone Marrow as Measured by SYBR Green I Polymerase Chain Reaction
N Pennell, A Woods, M Reis, R Buckstein, D Spaner, K Imrie, K Hewitt, A Boudreau, A Seth, NL Berinstein
The Journal of Molecular Diagnostics 2006
Current controversies in follicular lymphoma
V Aurora, JN Winter
Blood Reviews 2006
The Lymphomas
AL Feldman, S Pittaluga, ES Jaffe
The Lymphomas 2006
Role of the Cyclic AMP Response Element in the bcl-2 Promoter in the Regulation of Endogenous Bcl-2 Expression and Apoptosis in Murine B Cells
H Xiang, J Wang, LM Boxer
Molecular and cellular biology 2006
A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene
G Lang, WM Gombert, HJ Gould
Immunology 2005
Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in theBCL2 gene or by absence of the t(14;18) translocation
M Schraders, D Jong, P Kluin, P Groenen, H Krieken
The Journal of Pathology 2005
Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas
R Schmitz, C Renné, R Rosenquist, M Tinguely, V Distler, F Menestrina, M Lestani, T Stankovic, B Austen, A Bräuninger, ML Hansmann, R Küppers
Leukemia 2005
t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations
HV Aamot, M Bjornslett, J Delabie, S Heim
British Journal of Haematology 2005
Detection of BCL2-IGH Using Single-Round PCR Assays
M Gomez, X Wu, YL Wang
Diagnostic Molecular Pathology 2005
Bcl-2 and c-Myc co-operate in the Epstein – Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity
JL Tomlin, BA Guinn, LZ Penn, NL Berinstein
Leukemia & Lymphoma 2005
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan, CA Heckman, LM Boxer
Molecular and cellular biology 2005
Novel rapid tissue lysis method to evaluate cancer proteins: Correlation between elevated Bcl-XL expression and colorectal cancer cell proliferation
Wei-Shone Chen, Hong-Yi Chang, Jui-Ting Chang, Jacqueline Ming Liu, Chung-Pin Li, Li-Li Chen, Huei-Ling Chang, Chia-Chi Chen, Tze-Sing Huang
World journal of gastroenterology : WJG 2005
Genetic and epigenetic factors involved in B‐cell lymphomagenesis
Seto M
Cancer Science 2005
Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity
CK Youn, HJ Cho, SH Kim, HB Kim, MH Kim, IY Chang, JS Lee, MH Chung, KS Hahm, HJ You
Nature Cell Biology 2004
Genetic and epigenetic factors involved in B-cell lymphomagenesis
M Seto
Cancer Science 2004
CYTOCHROMEC-MEDIATEDAPOPTOSIS
X Jiang, X Wang
Annual Review of Biochemistry 2004
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray
H Zha, M Raffeld, L Charboneau, S Pittaluga, LW Kwak, E Petricoin, LA Liotta, ES Jaffe
Laboratory Investigation 2004
Molecular pathology in the diagnosis and treatment of non-Hodgkin's lymphomas
JR Krause, M Shahidi-Asl
Journal of Cellular and Molecular Medicine 2003
Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximab
C Hirt, F Schüler, G Dölken
Seminars in Cancer Biology 2003
Molecular Biology of B Cells
P Brandtzaeg, HC Morton, ME Lamm
Molecular Biology of B Cells 2003
Bcl-2 Protein Is Required for the Adenine/Uridine-rich Element (ARE)-dependent Degradation of Its Own Messenger
A Bevilacqua, MC Ceriani, G Canti, L Asnaghi, R Gherzi, G Brewer, L Papucci, N Schiavone, S Capaccioli, A Nicolin
The Journal of biological chemistry 2003
Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells
CA Heckman, MA Wheeler, LM Boxer
Oncogene 2003
Synthesis of Radiometal-Labeled and Fluorescent Cell-Permeating Peptide−PNA Conjugates for Targeting the bcl-2 Proto-oncogene
F Gallazzi, Y Wang, F Jia, N Shenoy, LA Landon, M Hannink, SZ Lever, MR Lewis
Bioconjugate Chemistry 2003
Molecular mechanisms of lymphomagenesis through transcriptional disregulation by chromosome translocation
M Seto
International Journal of Hematology 2002
Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18)
RS Robetorye, SD Bohling, JW Morgan, GC Fillmore, MS Lim, KS Elenitoba-Johnson
The Journal of Molecular Diagnostics 2002
Detection of BCL2 Rearrangements in Follicular Lymphoma
JC Aster, JA Longtine
The American Journal of Pathology 2002
Allele-specific analysis of transcription factors binding to promoter regions
CA Heckman, LM Boxer
Methods 2002
Apoptosis and Expression of BCL-2 in Facial Motoneurons after Facial Nerve Injury
ZM Wang, CF Dai, N Kanoh, FL Chi, KY Li
Otology & Neurotology 2002
Regulation of Bcl-2 Expression in Glioma Cells by All-trans Retinoic Acid
K HATAYAMA, T TACHIKAWA, A SASAKI, K MATSUMOTO
The Showa University Journal of Medical Sciences 2002
Apoptosis in Lymphocytic Leukemias and Lymphomas
EJ Schattner
Cancer Investigation 2002
Impaired Proliferation and Survival of Activated B Cells in Transgenic Mice That Express a Dominant-negative cAMP-response Element-binding Protein Transcription Factor in B Cells
C Zhang, YL Wu, LM Boxer
The Journal of biological chemistry 2002
NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells
CA Heckman, JW Mehew, LM Boxer
Oncogene 2002
In situ localization of follicular lymphoma: description and analysis by laser capture microdissection
P Cong, M Raffeld, J Teruya-Feldstein, L Sorbara, S Pittaluga, ES Jaffe
Blood 2002
Radiometal-Labeled Peptide−PNA Conjugates for Targeting bcl-2 Expression: Preparation, Characterization, and in Vitro mRNA Binding
MR Lewis, F Jia, F Gallazzi, Y Wang, J Zhang, N Shenoy, SZ Lever, M Hannink
Bioconjugate Chemistry 2002
Use of Novel t(11;14) and t(14;18) Dual-Fusion Fluorescence In Situ Hybridization Probes in the Differential Diagnosis of Lymphomas of Small Lymphocytes
JL Frater, EK Tsiftsakis, ED Hsi, J Pettay, RR Tubbs
Diagnostic Molecular Pathology 2001
Agricultural risk factors for t(14;18) subtypes of non-Hodgkin’s lymphoma
JC Schroeder, AF Olshan, R Baric, GA Dent, CR Weinberg, B Yount, JR Cerhan, CF Lynch, LM Schuman, PE Tolbert, N Rothman, KP Cantor, A Blair
Epidemiology 2001
bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements
G Papakonstantinou, C Verbeke, J Hastka, M Bohrer, R Hehlmann
British Journal of Haematology 2001
Causes and Consequences ofBCL2Overexpression in Diffuse Large B-Cell Lymphoma
S Rantanen, O Imonni, H Joensuu, K Franssila, S Knuutila
Leukemia & Lymphoma 2001
Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells
C Shen, A Buck, G Mehrke, B Polat, H Gross, M Bachem, S Reske
Nucleic Acids Research 2001
Expression and Replication Timing Patterns of Wildtype and Translocated BCL2 Genes
Y Sun, RT Wyatt, A Bigley, TG Krontiris
Genomics 2001
Systemic lupus erythematosus and B-cell hematologic neoplasm
Y Xu, PH Wiernik
Lupus 2001
Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain
J N Glasgow, J Qiu, D Rassin, M Grafe, T Wood, J R Perez-Pol
Neurochemical Research 2001
Antisense oligonucleotides complementary to immunoglobulin sequences of BCL-2/immunoglobulin fusion transcript induce apoptosis of t(14;18) lymphoma cells
MR Smith, T Xie, Z Zhou, I Joshi
British Journal of Haematology 2000
BCL-2 Regulation Targeting the AU-Rich Domain
A Bevilacqua, MC Ceriani, N Schiavone, A Nicolin
Nucleosides Nucleotides & Nucleic Acids 2000
Cancer and Autoimmunity
O Pritsch, G Dighiero
Cancer and Autoimmunity 2000
A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma Cells
CA Heckman, JW Mehew, GG Ying, M Introna, J Golay, LM Boxer
The Journal of biological chemistry 2000
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
HG Drexler, SM Gignac, R von Wasielewski, M Werner, WG Dirks
Leukemia 2000
One path to cell death in the nervous system
J Glasgow, R Perez-Polo
Neurochemical Research 2000
Recent advances in the molecular pathogenesis of lymphomas
A Sarris, R Ford
Current Opinion in Oncology 1999
Overexpression of Anti-apoptotic Gene BAG-1 in Human Cervical Cancer
X Yang, Y Hao, A Ferenczy, SC Tang, A Pater
Experimental Cell Research 1999
BCL2 Overexpression in Diffuse Large B-Cell Lymphoma
O Monni, K Franssila, H Joensuu, S Knuutila
Leukemia & Lymphoma 1999
Apoptosis: Biology and Mechanisms
S Kumar
1999
Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma
A López-Guillermo, F Cabanillas, TI McDonnell, P McLaughlin, T Smith, W Pugh, F Hagemeister, MA Rodrı́guez, JE Romaguera, A Younes, AH Sarris, HA Preti, MS Lee
Blood 1999
The role of autosomal cell apoptosis regulator genes in human spermatogenesis
W W Lin, D J Lamb, L I Lipshultz, E D Kim
International Urology and Nephrology 1999
Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia
Z Estrov, M Talpaz, S Ku, D Harris, Q Van, M Beran, C Hirsch-Ginsberg, Y Huh, G Yee, R Kurzrock
Leukemia Research 1998
Advances in Genome Biology
J Perdigão, CE Sunkel
Advances in Genome Biology 1998
Apoptotic Induction in Transformed Follicular Lymphoma Cells by Bcl-2 Downregulation
M Tormo, AM Tari, TJ McDonnell, F Cabanillas, J Garcia-Conde, G Lopez-Berestein
Leukemia & Lymphoma 1998
The Ig Heavy Chain 3′ End Confers a Posttranscriptional Processing Advantage to Bcl-2–IgH Fusion RNA in t(14;18) Lymphoma
AS Petrovic, RL Young, B Hilgarth, P Ambros, SJ Korsmeyer, U Jaeger
Blood 1998
Heterologous Promoters Fused to BCL6 by Chromosomal Translocations Affecting Band 3q27 Cause Its Deregulated Expression During B-Cell Differentiation
W Chen, S Iida, DC Louie, R Dalla-Favera, RS Chaganti
Blood 1998
The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas
A López-Guillermo, F Cabanillas, P McLaughlin, T Smith, F Hagemeister, MA Rodrı́guez, JE Romaguera, A Younes, AH Sarris, HA Preti, W Pugh, MS Lee
Blood 1998
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
A Strasser, DC Huang, DL Vaux
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1997
Identification of differentially expressed genes in chemically induced skin tumors
SE Rutberg, EJ Lee, LH Hansen, AB Glick, SH Yuspa
Molecular Carcinogenesis 1997
BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL)
M Butler, N Corbally, PA Dervan, DN Carney
British Journal of Cancer 1997
Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene
VE Nava, EH Cheng, M Veliuona, S Zou, RJ Clem, ML Mayer, JM Hardwick
Journal of virology 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
Molecular Pathways in Low Grade B-Cell Lymphoma
G Gaidano, C Pastore, D Capello, V Cilli, G Saglio
Leukemia & Lymphoma 1997
Bone Marrow Transplantation for Non-Hodgkin's Lymphoma:A Review
DE Salzman, AD Briggs, WP Vaughan
The American Journal of the Medical Sciences 1997
The WT1 Protein Is a Negative Regulator of the Normal bcl -2 Allele in t(14;18) Lymphomas
C Heckman, E Mochon, M Arcinas, LM Boxer
The Journal of biological chemistry 1997
BCL2 Overexpression Associated With Chromosomal Amplification in Diffuse Large B-Cell Lymphoma
O Monni, H Joensuu, K Franssila, J Klefstrom, K Alitalo, S Knuutila
Blood 1997
Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE)
QR Huang, D Morris, N Manolios
Rheumatology International 1996
Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome
N Ogawa, H Dang, L Kong, JM Anaya, GT Liu, N Talal
Arthritis & Rheumatism 1996
Use of the Polymerase Chain Reaction Technique to Determine c-myc Expression in Follicular Center Cell Lymphoma
J Wang, LJ Medeiros, DL Longo, A Mansoor, M Raffeld, PL Duffey, ES Jaffe, M Stetler-Stevenson
Diagnostic Molecular Pathology 1996
Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
BE Wilson, E Mochon, LM Boxer
Molecular and cellular biology 1996
Diagnostic and prognostic implications of genetic lesions in non-Hodgkin's lymphoma
G Gaidano, A Carbone
European Journal of Cancer 1996
Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells
LH Boise, PJ Noel, CB Thompson
Journal of immunology (Baltimore, Md. : 1950) 1996
c-Myc and Bcl-2 Protein Expression During the Induction of Apoptosis and Differentiation in TNFα-Treated HL-60 Cells
S Kumakura, H Ishikura, H Tsumura, Y Iwata, J Endo, S Kobayashi
Leukemia & Lymphoma 1996
CREB Proteins Function as Positive Regulators of the Translocated bcl -2 Allele in t(14;18) Lymphomas
L Ji, E Mochon, M Arcinas, LM Boxer
The Journal of biological chemistry 1996
Bcl-2 Gene Rearrangements in Lymphoid Malignancies
D Crisan
Clinics in Laboratory Medicine 1996
Advances in Lymphoma Research
F Cabanillas, MA Rodriguez
1996
Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in spermatogonia
T Furuchi, K Masuko, Y Nishimune, M Obinata, Y Matsui
Development (Cambridge, England) 1996
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
LH Boise, AJ Minn, PJ Noel, CH June, MA Accavitti, T Lindsten, CB Thompson
Immunity 1995
Flow cytometric analysis of apoptosis and BCL-2 in human solid neoplasms
KD Steck, TJ McDonnell, AK El-Naggar
Cytometry 1995
Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias*
JA Triscott, JH Ritter, PE Swanson, MR Wick
Journal of Cutaneous Pathology 1995
Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53
XH Liang, S Mungal, A Ayscue, JD Meissner, P Wodnicki, D Hockenbery, S Lockett, B Herman
Journal of Cellular Biochemistry 1995
Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus
WJ Tax, C Kramers, MC van Bruggen, JH Berden
Kidney International 1995
Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells
HM Chen, LM Boxer
Molecular and cellular biology 1995
Proliferative Fraction and DNA Content are Lower in B-Cell Non-Hodgkin's Lymphomas with the (t14; 18)
HL Grierson, TN Wooldridge, M Hess, A Ratashak, L Wooldridge, RF Ce-Boyer, M Bast, JO Armitage, DD Weisenburger, WG Sanger
Leukemia & Lymphoma 1995
Mechanisms in B-Cell Neoplasia 1994
M Potter, F Melchers
1995
Cellular Cancer Markers
CT Garrett, S Sell
1995
Technical and Biological Components of Marrow Transplantation
CD Buckner, RA Clift
1995
The Genetics of Cancer
BA Ponder, MJ Waring
The Genetics of Cancer 1995
High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis
JL Gala, C Vermylen, G Cornu, A Ferrant, JL Michaux, M Philippe, P Martiat
Annals of Hematology 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
AP Jewell, CP Worman, PM Lydyard, KL Yong, FJ Giles, AH Goldstone
British Journal of Haematology 1994
Somatic Hypermutations in the Immunoglobulin Genes of Two New Human Lymphoma Lines of Lymphatic Follicle Origin
HY Wu, T Tuomikoski, M Eray, P Mattila, S Knuutila, M Kaartinen
Scandinavian Journal of Immunology 1994
Analysis of the Role of bcl-2 in Apoptosis
CJ Hawkins, DL Vaux
Immunological Reviews 1994
High levels ofbcl-2 protein in circulating t lymphocytes, but not b lymphocytes, of patients with systemic lupus erythematosus
M Aringer, W Wintersberger, CW Steiner, H Kiener, E Presterl, U Jaeger, JS Smolen, WB Graninger
Arthritis & Rheumatism 1994
Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line
R Ascaso, J Marvel, MK Collins, A López-Rivas
European Journal of Immunology 1994
Bcl-2 and Fas, Molecules Which Influence Apoptosis. A Possible Role in Systemic Lupus Erythematosus?
LM Rose, DS Latchman, DA Isenberg
Autoimmunity 1994
Two novel human B-cell lymphoma lines of lymphatic follicle origin: Cytogenetic, molecular genetic and histopathological characterisation
S Knuutila, J Klefström, J Szymanska, T Lakkala, P Peltomäki, M Eray, L Teerenhovi, E Elonen, KO Franssila, M Kaartinen
European Journal of Haematology 1994
Transcription Factors as Molecular Mediators in Cell Death
HD Soares, T Curran, JI Morgan
Annals of the New York Academy of Sciences 1994
bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
RD Leek, L Kaklamanis, F Pezzella, KC Gatter, AL Harris
British Journal of Cancer 1994
Bcl-2 expression in human melanocytes and melanocytic tumors
JJ van Oord, N Vandeghinste, MD Ley, CD Wolf-Peeters
The American Journal of Pathology 1994
Bcl-2 protein expression during murine development
DV Novack, SJ Korsmeyer
The American Journal of Pathology 1994
Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas
J Klefstrom, K Franssila, P Peltomäki, M Kaartinen, ML Solin, S Knuutila
Leukemia Research 1994
Apoptosis as programmed cell death (PCD): Cupio dissolvi in cell life
S Pileri, S Poggi, E Sabattini, S Santucci, G Melilli, B Falini, P Tosi
Current Diagnostic Pathology 1994
Expression of Bcl-2 Protein and Bcl-2 mRNA in Normal and Neoplastic Lymphoid Tissues
T Akagi, E Kondo, T Yoshino
Leukemia & Lymphoma 1994
Interleukin-8 and Related Chemotactic Cytokines
M Baggiolini, B Moser, I Clark-Lewis
Chest 1994
bcl-2 regulation in normal resting lymphocytes and lymphoblasts
E Kondo, T Yoshino, S Nomura, S Nakamura, K Takahashi, N Teramoto, K Hayashi, T Akagi
Japanese journal of cancer research : Gann 1994
Rearrangement of bcl-2 is detectable in Hodgkin's disease by polymerase chain reaction
S Mitani, T Oka, N Aoki, I Hojo, U Ota, S Mori
Japanese journal of cancer research : Gann 1994
The polymerase chain reaction in diagnosing lymphoid disorders
KP McCarthy, DN Slack, JP Sloane
Molecular Biology Reports 1994
bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS
DE Merry, DJ Veis, WF Hickey, SJ Korsmeyer
Development (Cambridge, England) 1994
bcl‐2 Regulation in Normal Resting Lymphocytes and Lymphoblasts
Kendo E, Yoshino T, Nomura S, Nakamura S, Takahashi K, Teramoto N, Hayashi K, Akagi T
Japanese journal of cancer research : Gann 1994
Rearrangement of bcl‐2 Is Detectable in Hodgkin's Disease by Polymerase Chain Reaction
Mitani S, Oka T, Aoki N, Hōjō I, ōta U, Mori S
Japanese journal of cancer research : Gann 1994
bcl-2 Rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features
JO Jacobson, BM Wilkes, DJ Kwiatkowski, LJ Medeiros, AC Aisenberg, NL Harris
Cancer 1993
BCL-2 expression in adult and embryonic non-haematopoietic tissues
QL Lu, R Poulsom, L Wong, AM Hanby
The Journal of Pathology 1993
Cell division versus cell death: A functional model of multistep neoplasia
TJ McDonnell
Molecular Carcinogenesis 1993
Bcl-2 proto-oncogene expression in epstein-barr-virus-associated nasopharyngeal carcinoma
QL Lu, G Elia, S Lucas, JA Thomas
International Journal of Cancer 1993
Molecular analysis of a variant 18;22 translocation in a case of lymphocytic lymphoma
P Seité, D Leroux, J Hillion, M Monteil, R Berger, D Mathieu-Mahul, CJ Larsen
Genes, Chromosomes and Cancer 1993
The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis
TE Allsopp, S Wyatt, HF Paterson, AM Davies
Cell 1993
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
LH Boise, M González-García, CE Postema, L Ding, T Lindsten, LA Turka, X Mao, G Nuñez, CB Thompson
Cell 1993
bcl-2 rearrangement in Hodgkin's disease. Results of polymerase chain reaction, flow cytometry, and sequencing on formalin-fixed, paraffin-embedded tissue
AH Reid, RE Cunningham, G Frizzera, TJ O'Leary
The American Journal of Pathology 1993
A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter
RL Young, SJ Korsmeyer
Molecular and cellular biology 1993
Immature surface Ig+ B cells can continue to rearrange kappa and lambda L chain gene loci
A Rolink, U Grawunder, D Haasner, A Strasser, F Melchers
Journal of Experimental Medicine 1993
Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes
GA Silverman, E Yang, JH Proffitt, M Zutter, SJ Korsmeyer
Molecular and cellular biology 1993
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2
KM Kozopas, T Yang, HL Buchan, P Zhou, RW Craig
Proceedings of the National Academy of Sciences 1993
The Role of Bcl-2 in the Pathogenesis of B Chronic Lymphocytic Leukemia
M Schena, D Gottardi, P Ghia, LG Larsson, M Carlsson, K Nilsson, F Caligaris-Cappio
Leukemia & Lymphoma 1993
Investigation of BCL-2 Gene Rearrangements in a United Kingdom Series of Low and High Grade Non-Hodgkin's Lymphomas
K Lee, J Goepel, D Winfield, B Hancock, M Goyns
Leukemia & Lymphoma 1993
bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens
S Mitani, N Aoki, S Mizutani, M Fujiwara, T Kitagawa, T Uehara, S Mori
Japanese journal of cancer research : Gann 1993
Oncogenes and Tumor Suppressor Genes in Human Malignancies
CC Benz, ET Liu
1993
Leukemia: Advances in Research and Treatment
EJ Freireich, H Kantarjian
1993
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems
BW Dana
1993
bcl‐2 Gene Rearrangement Analysis of Japanese Follicular Lymphomas by Polymerase Chain Reaction in Formalin‐fixed, Paraffin‐embedded Tissue Specimens
Mitani S, Aoki N, Mizutani S, Fujiwara M, Kitagawa T, Uehara T, Mori S
Japanese journal of cancer research : Gann 1993
Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells
A Aiello, D Delia, MG Borrello, D Biassoni, R Giardini, E Fontanella, F Pezzella, K Pulford, M Pierotti, GD Porta
Cytometry 1992
Negative regulators of programed cell death
RE Ellis
Current Opinion in Genetics & Development 1992
Comparative Expression of Adult and Fetal V Gene Repertoires
JM Teale, CA Medina
International Reviews of Immunology 1992
BCL2 gene: Current relevance to clinical oncology
M Brada
European Journal of Cancer 1992
Expression of the bcl-2 oncogene product and chromosomal translocation t(14; 18) in Hodgkin's disease
J Lorenzen, ML Hansmann, F Pezzella, C Hesse, M Kneba, KC Gatter, R Fischer
Human Pathology 1992
Mechanisms in B-Cell Neoplasia 1992
M Potter, F Melchers
1992
Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma
W Fiedler, HJ Weh, W Zeller, C Fonatsch, J Hillion, C Larsen, B Wörmann, DK Hossfeld
Annals of Hematology 1991
The molecular biology of B-cell lymphoma: Clinicopathologic implications
PM Kluin, JH Krieken
Annals of Hematology 1991
Involvement of theBCL2Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle
P Cornillet, R Rimokh, FÇ Berger, M Ffrench, JP Rouault, K Wahbi, PA Bryon, O Gentilhomme, B Coiffier, D Germain, JP Magaud
Leukemia & Lymphoma 1991
Transgenic models for haemopoietic malignancies
JM Adams, S Cory
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1991
Structural Alterations in the 5′ Region of the BCL2 Gene in Follicular Lymphomas WithBCL2-MBR orBCL2-MCR Rearrangements
V Mikraki, M Ladanyi, RS Chaganti
Genes, Chromosomes and Cancer 1991
High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients
EK Pisa, P Pisa, HI Kang, RI Fox
Journal of Experimental Medicine 1991
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
A Strasser, S Whittingham, DL Vaux, ML Bath, JM Adams, S Cory, AW Harris
Proceedings of the National Academy of Sciences 1991
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
DM Hockenbery, M Zutter, W Hickey, M Nahm, SJ Korsmeyer
Proceedings of the National Academy of Sciences 1991
Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease
DC Louie, JA Kant, JJ Brooks, JC Reed
The American Journal of Pathology 1991
Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma
JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ML Grossbard, SN Rabinowe, F Coral, GJ Freeman, J Ritz, LM Nadler
New England Journal of Medicine 1991
Rearrangements of immunoglobulin gene and oncogenes in ocular adnexal pseudolymphoma
PM Chen, JH Liu, SH Lin, WM Hsu, SC Kao
Current Eye Research 1991
Bcl-2 maintains B cell memory
G Nuñez, D Hockenbery, TJ McDonnell, CM Sorensen, SJ Korsmeyer
Nature 1991
Altered gene expression and oncogenesis of B-cell neoplasia
FE Cotter, E Zucca
Annals of Oncology 1991
The molecular biology of B-cell lymphoma: Clinicopathologic implications
PM Kluin, JH van Krieken
Annals of Hematology 1991
THE ROLE OF THE bcl-2 GENE IN LYMPHOMA
FE Cotter
British Journal of Haematology 1990
Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene
GA Silverman, ED Green, RL Young, JI Jockel, PH Domer, SJ Korsmeyer
Proceedings of the National Academy of Sciences 1990
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation
F Pezzella, AG Tse, JL Cordell, KA Pulford, KC Gatter, DY Mason
The American Journal of Pathology 1990
Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population
TJ McDonnell, G Nunez, FM Platt, D Hockenberry, L London, JP McKearn, SJ Korsmeyer
Molecular and cellular biology 1990
The new genetics and non-Hodgkin lymphoma
MJ Dyer
European Journal of Cancer and Clinical Oncology 1990
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
D Hockenbery, G Nuñez, C Milliman, RD Schreiber, SJ Korsmeyer
Nature 1990
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
A Strasser, AW Harris, ML Bath, S Cory
Nature 1990
Mechanisms in B-Cell Neoplasia 1990
M Potter, F Melchers
1990
Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro
Z Chen-Levy, ML Cleary
The Journal of biological chemistry 1990
Chromosome rearrangements in lymphoid neoplasms
AS Jack, AW Boylston
Current Opinion in Immunology 1989
bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
TJ McDonnell, N Deane, FM Platt, G Nunez, U Jaeger, JP McKearn, SJ Korsmeyer
Cell 1989
The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation
Z Chen-Levy, J Nourse, ML Cleary
Molecular and cellular biology 1989
Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells
G Nunez, M Seto, S Seremetis, D Ferrero, F Grignani, SJ Korsmeyer, R Dalla-Favera
Proceedings of the National Academy of Sciences 1989
Mechanism of antigen-driven selection in germinal centres
YJ Liu, DE Joshua, GT Williams, CA Smith, J Gordon, IC MacLennan
Nature 1989
Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease
M Crescenzi, M Seto, GP Herzig, PD Weiss, RC Griffith, SJ Korsmeyer
Proceedings of the National Academy of Sciences 1988
Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma
M Seto, U Jaeger, RD Hockett, W Graninger, S Bennett, P Goldman, SJ Korsmeyer
The EMBO Journal 1988
The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasia
I Magrath, F Barriga, M McManaway, B Shiramizu
Journal of Virological Methods 1988
Expression in Non-Hodgkin's Lymphoma of the bcl -2 Protein Associated with the t(14;18) Chromosomal Translocation
BY Ngan, Z Chen-Levy, LM Weiss, RA Warnke, ML Cleary
New England Journal of Medicine 1988
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
DL Vaux, S Cory, JM Adams
Nature 1988
Mechanisms in B-Cell Neoplasia 1988
M Potter, F Melchers
1988
Oncogenes
CT Garrett
Clinica Chimica Acta 1986
Progress in Immunology
IH Lepow
Progress in Immunology 1971

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
32 readers on Mendeley
See more details